A Colorado company claims it could have prevented this week's E. coli outbreak linked to the National Western Stock Show.
"It's a very simple process," said Dr. Tony Milici, President of Genethera.
The Wheat Ridge biotech company is developing an E. coli vaccine. The new drug, called E-co Guard, has been proven 99 percent successful in the first phase of testing with rabbits, according to Milici. But it has a long way to go before it hits the market.
The next step — which is about to begin — is clinical testing with cattle.
"It's very important that clinical trials illustrate it can be effective," said Terry Fankhauser, Colorado Cattlemen's Association Executive Vice President.
E. coli bacteria occurs naturally in the digestive track. he bacteria in cattle is toxic to humans and can be fatal.
E-co Guard essentially neutralizes the toxicity so the bacteria is harmless to people.
But funding has dried up with the bad economy.
"We've been trying to partner with larger companies," Milici said.
The company estimates a single shot inoculation would cost $20.
Source: CBS 4 Denver
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer